ESC Premium Access

The novel small leucin-rich repeat protein podocan is an independent predictor of major adverse cardiac events in patients with angiographically-defined coronary artery disease

Congress Session

About the speaker

Doctor Kanramon watthanasuntorn

Bassett Healthcare, Cooperstown (United States of America)
0 follower

6 more presentations in this session

Novel biomarker algorithmic panel measuring permutations of immune response to cardiac endothelial injury and global risk factors identifies patients at risk of acute coronary syndrome (ACS)

Speaker: Professor D. Harrington (Irvine, US)

Thumbnail

Serum sLOX-1 concentrations are associated with 2- year major adverse cardiovascular and cerebrovascular events in patients after percutaneous coronary intervention: A multicenter pilot study

Speaker: Doctor Z. Zhao (Fuzhou, CN)

Thumbnail

Plasma proteomics in healthy individuals predict myocardial infarction

Speaker: Ms R. Hoogeveen (Amsterdam, NL)

Thumbnail

The protein APRIL predicts adverse outcomes in DAPT patients better than NT-proBNP and troponin

Speaker: Professor C. Pemberton (Christchurch, NZ)

Thumbnail

GLP-1 levels predict cardiovascular risk in patients with acute myocardial infarction

Speaker: Doctor M. Lehrke (Aachen, DE)

Thumbnail

Access the full session

Poster Session 2 - Acute Coronary Syndromes: Biomarkers

Speakers: Doctor K. watthanasuntorn, Professor D. Harrington, Doctor Z. Zhao, Ms R. Hoogeveen, Professor C. Pemberton...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk